Home
CALT
CALT News

Latest Calliditas Therapeutics AB (CALT) News on July 27, 2024

Calliditas partner STADA receives European Commission decision for full approval of Kinpeygo® for the treatment of IgA Nephropathy

PR Newswire

9 hours ago

Calliditas partner STADA receives European Commission decision for full approval of Kinpeygo® for the treatment of IgA Nephropathy

Calliditas’ Phase IIb trial of PBC treatment meets primary endpoint

Clinical Trials Arena

14 hours ago

Calliditas’ Phase IIb trial of PBC treatment meets primary endpoint

MT Newswires

15 hours ago

Calliditas Therapeutics Says Liver Disease Therapy Met Main Goal in Phase 2b Study

Calliditas announces positive TRANSFORM Phase 2b topline data in primary biliary cholangitis

PR Newswire

18 hours ago

Calliditas announces positive TRANSFORM Phase 2b topline data in primary biliary cholangitis

MT Newswires

22 days ago

Calliditas Therapeutics' Partner Launches Japanese Trial for IgA Nephropathy Treatment

Launch of Phase 3 clinical trial with Nefecon in Japan

PR Newswire

23 days ago

Launch of Phase 3 clinical trial with Nefecon in Japan

MT Newswires

a month ago

Calliditas Therapeutics Gets US Patent for Cancer Treatment Candidate

Calliditas provides setanaxib patent update

PR Newswire

a month ago

Calliditas provides setanaxib patent update

Bulletin from the annual general meeting of Calliditas Therapeutics AB (publ)

PR Newswire

a month ago

Bulletin from the annual general meeting of Calliditas Therapeutics AB (publ)

MT Newswires

2 months ago

Citigroup Downgrades Calliditas Therapeutics to Neutral From Buy, Price Target at $39

Swedish Growth Companies With High Insider Ownership Spotlight May 2024

Simply Wall St.

2 months ago

Swedish Growth Companies With High Insider Ownership Spotlight May 2024

MT Newswires

2 months ago

Calliditas Therapeutics Receives Positive Opinion for Kinpeygo Marketing Authorization in Europe

Calliditas partner STADA receives positive CHMP opinion recommending full approval for Kinpeygo® for the treatment of IgA nephropathy

PR Newswire

2 months ago

Calliditas partner STADA receives positive CHMP opinion recommending full approval for Kinpeygo® for the treatment of IgA nephropathy

Swedish Exchange Highlights: 3 Growth Companies With High Insider Ownership

Simply Wall St.

2 months ago

Swedish Exchange Highlights: 3 Growth Companies With High Insider Ownership

Swedish Exchange Growth Leaders: 3 Companies With Significant Insider Ownership

Simply Wall St.

2 months ago

Swedish Exchange Growth Leaders: 3 Companies With Significant Insider Ownership

MT Newswires

2 months ago

HC Wainwright Downgrades Calliditas Therapeutics to Neutral From Buy, Cuts Price Target to $39 From $45

Calliditas Therapeutics Presents Data at the 61st European Renal Association Congress

PR Newswire

2 months ago

Calliditas Therapeutics Presents Data at the 61st European Renal Association Congress

MT Newswires

2 months ago

Top Premarket Gainers

Asahi Kasei offers to buy Sweden’s Calliditas for $1.04bn

Pharmaceutical Technology

2 months ago

Asahi Kasei offers to buy Sweden’s Calliditas for $1.04bn

MT Newswires

2 months ago

Calliditas Therapeutics' Board Urges Shareholders to Embrace $1.06 Billion Buyout Offer

Asahi Kasei to Buy Swedish Biotech for Rare Disease Drug

Bloomberg

2 months ago

Asahi Kasei to Buy Swedish Biotech for Rare Disease Drug

Asahi Kasei Makes $1.1 Billion Bid For Swedish Calliditas Therapeutics

The Wall Street Journal

2 months ago

Asahi Kasei Makes $1.1 Billion Bid For Swedish Calliditas Therapeutics

Calliditas Therapeutics Gets $1.1 Billion Takeover Bid From Asahi Kasei

The Wall Street Journal

2 months ago

Calliditas Therapeutics Gets $1.1 Billion Takeover Bid From Asahi Kasei

Statement by the Board of Directors of Calliditas Therapeutics AB (publ) in relation to the public offer by Asahi Kasei Corporation

PR Newswire

2 months ago

Statement by the Board of Directors of Calliditas Therapeutics AB (publ) in relation to the public offer by Asahi Kasei Corporation

Calliditas Q1 report, January - March 2024

PR Newswire

2 months ago

Calliditas Q1 report, January - March 2024

In-Person & Virtual R&D Day: The Anti-Fibrotic Effects of Setanaxib and TARPEYO's Mode of Action

PR Newswire

2 months ago

In-Person & Virtual R&D Day: The Anti-Fibrotic Effects of Setanaxib and TARPEYO's Mode of Action

Invitation to the presentation of Calliditas´s interim report January - March 2024

PR Newswire

2 months ago

Invitation to the presentation of Calliditas´s interim report January - March 2024

Calliditas Therapeutics to Present Data at ERA 2024 May 23 - 26 in Stockholm

PR Newswire

2 months ago

Calliditas Therapeutics to Present Data at ERA 2024 May 23 - 26 in Stockholm

Notice of annual general meeting of Calliditas Therapeutics AB (publ)

PR Newswire

2 months ago

Notice of annual general meeting of Calliditas Therapeutics AB (publ)

Exploring Three Swedish Growth Companies With High Insider Ownership On The Swedish Exchange

Simply Wall St.

2 months ago

Exploring Three Swedish Growth Companies With High Insider Ownership On The Swedish Exchange

MT Newswires

2 months ago

Calliditas Therapeutics Partner Offers Nefecon in China; Shares Rise

Calliditas' Partner Everest Medicines Starts Commercial Launch of Nefecon in China

PR Newswire

2 months ago

Calliditas' Partner Everest Medicines Starts Commercial Launch of Nefecon in China

MT Newswires

3 months ago

Calliditas Therapeutics' Potential Head and Neck Cancer Treatment Meets Secondary Endpoints

Calliditas announces positive topline results of Phase 2 head and neck cancer trial with lead NOX inhibitor candidate, setanaxib

PR Newswire

3 months ago

Calliditas announces positive topline results of Phase 2 head and neck cancer trial with lead NOX inhibitor candidate, setanaxib

Xencor (XNCR) Moves 14.3% Higher: Will This Strength Last?

Zacks

3 months ago

Xencor (XNCR) Moves 14.3% Higher: Will This Strength Last?

Calliditas Therapeutics' 2023 Annual Report Published

PR Newswire

3 months ago

Calliditas Therapeutics' 2023 Annual Report Published

MT Newswires

3 months ago

Calliditas Therapeutics Says OLE Study Shows Treatment Response Consistent With Late-Stage NefIgArd Study's Findings

Calliditas Announces Positive NefIgArd Open Label Extension Results

PR Newswire

3 months ago

Calliditas Announces Positive NefIgArd Open Label Extension Results

Calliditas Therapeutics Presents Additional Data Analyses from the Phase 3 NeflgArd trial of Nefecon in Primary IgA Nephropathy at the ISN World Congress of Nephrology 2024

PR Newswire

3 months ago

Calliditas Therapeutics Presents Additional Data Analyses from the Phase 3 NeflgArd trial of Nefecon in Primary IgA Nephropathy at the ISN World Congress of Nephrology 2024

Novartis (NVS) Presents Positive Data on Rare Kidney Disease Drug

Zacks

3 months ago

Novartis (NVS) Presents Positive Data on Rare Kidney Disease Drug

Calliditas Therapeutics to Attend Conferences in April

PR Newswire

4 months ago

Calliditas Therapeutics to Attend Conferences in April

Calliditas Therapeutics to Present Nefecon Data at the ISN World Congress of Nephrology April 13 - 16 in Buenos Aires

PR Newswire

4 months ago

Calliditas Therapeutics to Present Nefecon Data at the ISN World Congress of Nephrology April 13 - 16 in Buenos Aires

Calliditas receives notice of allowance for United States patent application covering setanaxib in cancer treatment

PR Newswire

4 months ago

Calliditas receives notice of allowance for United States patent application covering setanaxib in cancer treatment

Everest Medicines' Partner Calliditas Therapeutics Announces U.S. FDA Grants an Additional Seven-Year Orphan Drug Exclusivity Period for Nefecon®

PR Newswire

5 months ago

Everest Medicines' Partner Calliditas Therapeutics Announces U.S. FDA Grants an Additional Seven-Year Orphan Drug Exclusivity Period for Nefecon®

Calliditas announces an additional seven year orphan drug exclusivity period for TARPEYO®

PR Newswire

5 months ago

Calliditas announces an additional seven year orphan drug exclusivity period for TARPEYO®

Calliditas Therapeutics to Attend Investor Conferences in March

PR Newswire

5 months ago

Calliditas Therapeutics to Attend Investor Conferences in March

Calliditas Therapeutics AB (publ) (NASDAQ:CALT) Q4 2023 Earnings Call Transcript

Insider Monkey

5 months ago

Calliditas Therapeutics AB (publ) (NASDAQ:CALT) Q4 2023 Earnings Call Transcript

Calliditas Year-end report, January - December 2023

PR Newswire

5 months ago

Calliditas Year-end report, January - December 2023

Invitation to the presentation of Calliditas´ Year-end report January - December 2023

PR Newswire

5 months ago

Invitation to the presentation of Calliditas´ Year-end report January - December 2023

Calliditas provides patent update

PR Newswire

5 months ago

Calliditas provides patent update

Why Canadian Solar (CSIQ) Dipped More Than Broader Market Today

Zacks

6 months ago

Why Canadian Solar (CSIQ) Dipped More Than Broader Market Today

Green Plains to Host Fourth Quarter and Full Year 2023 Earnings Conference Call on February 7, 2024

Business Wire

6 months ago

Green Plains to Host Fourth Quarter and Full Year 2023 Earnings Conference Call on February 7, 2024

3 Stocks to Sell Before They Become Obsolete in 2024

InvestorPlace

6 months ago

3 Stocks to Sell Before They Become Obsolete in 2024

CBL Properties Announces Tax Reporting Information for 2023 Common Stock Dividends

Business Wire

6 months ago

CBL Properties Announces Tax Reporting Information for 2023 Common Stock Dividends

Origin Bancorp, Inc. Reports Earnings For Fourth Quarter and 2023 Full Year

GlobeNewswire

6 months ago

Origin Bancorp, Inc. Reports Earnings For Fourth Quarter and 2023 Full Year

Teledyne Technologies (TDY) Surpasses Q4 Earnings Estimates

Zacks

6 months ago

Teledyne Technologies (TDY) Surpasses Q4 Earnings Estimates

Inhibrx Soared 176% Over Two Months — Now, Sanofi Is Buying It

Investor's Business Daily

6 months ago

Inhibrx Soared 176% Over Two Months — Now, Sanofi Is Buying It

Kaman (KAMN) Soars 100.9%: Is Further Upside Left in the Stock?

Zacks

6 months ago

Kaman (KAMN) Soars 100.9%: Is Further Upside Left in the Stock?

Cohen & Steers Announces Retirement of William Scapell, Head of Fixed Income and Preferred Securities, Effective August 1, 2024

PR Newswire

6 months ago

Cohen & Steers Announces Retirement of William Scapell, Head of Fixed Income and Preferred Securities, Effective August 1, 2024

Camping World Announces Review of Potential Strategic Alternatives for Good Sam Business

Business Wire

6 months ago

Camping World Announces Review of Potential Strategic Alternatives for Good Sam Business

B&G Foods (BGS) Gains on Pricing & Portfolio Refining Efforts

Zacks

6 months ago

B&G Foods (BGS) Gains on Pricing & Portfolio Refining Efforts

AMC Networks (NASDAQ:AMCX) Could Be Struggling To Allocate Capital

Simply Wall St.

6 months ago

AMC Networks (NASDAQ:AMCX) Could Be Struggling To Allocate Capital

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Has Fared Decently But Fundamentals Look Uncertain: What Lies Ahead For The Stock?

Simply Wall St.

6 months ago

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Has Fared Decently But Fundamentals Look Uncertain: What Lies Ahead For The Stock?

Best Momentum Stocks to Buy for January 11th

Zacks

6 months ago

Best Momentum Stocks to Buy for January 11th

Bitcoin mining CEO calls ETF 'great entry point' for crypto

Yahoo Finance Video

7 months ago

Bitcoin mining CEO calls ETF 'great entry point' for crypto

Luminar and Mercedes-Benz Expand Partnership to Formula 1 with the Mercedes-AMG PETRONAS Team

Business Wire

7 months ago

Luminar and Mercedes-Benz Expand Partnership to Formula 1 with the Mercedes-AMG PETRONAS Team

Why 2024 could be the year of media dealmaking

Yahoo Finance

7 months ago

Why 2024 could be the year of media dealmaking

Calliditas Therapeutics provides business update ahead of JP Morgan conference

PR Newswire

7 months ago

Calliditas Therapeutics provides business update ahead of JP Morgan conference

Calliditas Therapeutics appoints Maria Törnsén as President North America

PR Newswire

7 months ago

Calliditas Therapeutics appoints Maria Törnsén as President North America

Calliditas to present at JP Morgan Healthcare Conference

PR Newswire

7 months ago

Calliditas to present at JP Morgan Healthcare Conference

Fubo to Participate in 26th Annual Needham Growth Conference

Business Wire

7 months ago

Fubo to Participate in 26th Annual Needham Growth Conference

Kratos and Rancher Government Solutions Announce Strategic Partnership to Enable Customers to Seamlessly Deploy and Scale Virtual Ground Systems Using Kratos’ OpenSpace® Software Platform

GlobeNewswire

7 months ago

Kratos and Rancher Government Solutions Announce Strategic Partnership to Enable Customers to Seamlessly Deploy and Scale Virtual Ground Systems Using Kratos’ OpenSpace® Software Platform

New Published Data Demonstrates Correlation Between Itch Cytokine Interleukin-31 Reduction and Pruritis Improvement in Primary Biliary Cholangitis in Phase 3 Post-Hoc Analysis of CymaBay's Seladelpar

PR Newswire

7 months ago

New Published Data Demonstrates Correlation Between Itch Cytokine Interleukin-31 Reduction and Pruritis Improvement in Primary Biliary Cholangitis in Phase 3 Post-Hoc Analysis of CymaBay's Seladelpar

Pliant Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

7 months ago

Pliant Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Retail Media Innovator Melanie Zimmermann joins Criteo to Lead its Global Retail Media Practice

PR Newswire

7 months ago

Retail Media Innovator Melanie Zimmermann joins Criteo to Lead its Global Retail Media Practice

B&G Foods' (BGS) Strategies Position it Well for Growth in 2024

Zacks

7 months ago

B&G Foods' (BGS) Strategies Position it Well for Growth in 2024

ICL to Develop Customer Innovation and Qualification Center

Zacks

7 months ago

ICL to Develop Customer Innovation and Qualification Center

Is Accel Entertainment (ACEL) Outperforming Other Consumer Discretionary Stocks This Year?

Zacks

7 months ago

Is Accel Entertainment (ACEL) Outperforming Other Consumer Discretionary Stocks This Year?

Calliditas refinances existing term loan with Euro 92 million senior secured facility with Athyrium Capital

PR Newswire

7 months ago

Calliditas refinances existing term loan with Euro 92 million senior secured facility with Athyrium Capital

Fluor Corporation and Align Technology have been highlighted as Zacks Bull and Bear of the Day

Zacks

7 months ago

Fluor Corporation and Align Technology have been highlighted as Zacks Bull and Bear of the Day

Calliditas Therapeutics announces full FDA approval of TARPEYO®, the only FDA-approved treatment for IgA nephropathy to significantly reduce the loss of kidney function

PR Newswire

7 months ago

Calliditas Therapeutics announces full FDA approval of TARPEYO®, the only FDA-approved treatment for IgA nephropathy to significantly reduce the loss of kidney function

Reuters

7 months ago

US FDA approves Sweden-based Calliditas' kidney disease drug

Kayne Anderson Energy Infrastructure Fund Announces Distribution of $0.22 per Share for Q4 2023

GlobeNewswire

7 months ago

Kayne Anderson Energy Infrastructure Fund Announces Distribution of $0.22 per Share for Q4 2023

High-Voltage, Automotive-Compliant, Hall-Effect Latches from Diodes Incorporated Provide Improved Resistance to Physical Stress

Business Wire

7 months ago

High-Voltage, Automotive-Compliant, Hall-Effect Latches from Diodes Incorporated Provide Improved Resistance to Physical Stress

7 Dividend Stocks I Wouldn’t Touch With a 10-Foot Pole

InvestorPlace

7 months ago

7 Dividend Stocks I Wouldn’t Touch With a 10-Foot Pole

PR Newswire

8 months ago

Calliditas Receives Notice of Allowance for United States Patent Application Covering TARPEYO®

NeoGames’ Pariplay signs deal with Tipico US for further North American growth

GlobeNewswire

8 months ago

NeoGames’ Pariplay signs deal with Tipico US for further North American growth

Recent Price Trend in HNI (HNI) is Your Friend, Here's Why

Zacks

8 months ago

Recent Price Trend in HNI (HNI) is Your Friend, Here's Why

Sidoti Events, LLC's Virtual December Small-Cap Conference

ACCESSWIRE

8 months ago

Sidoti Events, LLC's Virtual December Small-Cap Conference

PR Newswire

8 months ago

Calliditas announces additions to the management team

Insider Sell Alert: Senior Vice President Daniel Malan Sells Shares of Kelly Services Inc (KELYA)

GuruFocus.com

8 months ago

Insider Sell Alert: Senior Vice President Daniel Malan Sells Shares of Kelly Services Inc (KELYA)

Those who invested in Teekay (NYSE:TK) three years ago are up 185%

Simply Wall St.

8 months ago

Those who invested in Teekay (NYSE:TK) three years ago are up 185%

Insider Buying: Director MURPHY PAUL B JR Acquires Shares of Natural Resources Partners LP

GuruFocus.com

8 months ago

Insider Buying: Director MURPHY PAUL B JR Acquires Shares of Natural Resources Partners LP

HealthStream, Inc. (NASDAQ:HSTM) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?

Simply Wall St.

8 months ago

HealthStream, Inc. (NASDAQ:HSTM) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?

Ero Copper Completes US$111 Million Bought Deal Financing

GlobeNewswire

8 months ago

Ero Copper Completes US$111 Million Bought Deal Financing

ScanSource (SCSC) Q1 Earnings Miss Estimates, Decline Y/Y

Zacks

8 months ago

ScanSource (SCSC) Q1 Earnings Miss Estimates, Decline Y/Y

Business Wire

9 months ago

Paramount Achieves GRESB 5 Star Rating for Fifth Consecutive Year

ARKO Corp. Reports Third Quarter 2023 Results

GlobeNewswire

9 months ago

ARKO Corp. Reports Third Quarter 2023 Results

Ero Copper Announces US$105 Million Bought Deal Financing

GlobeNewswire

9 months ago

Ero Copper Announces US$105 Million Bought Deal Financing

Paramount Group, Inc. (NYSE:PGRE) Q3 2023 Earnings Call Transcript

Insider Monkey

9 months ago

Paramount Group, Inc. (NYSE:PGRE) Q3 2023 Earnings Call Transcript

Share on Social Networks: